Saillant Therapeutics Reports Proof of Concept of Its Treatment In Heart Failure Showing Functional Reversal and Myocardial Rejuvenation

The compound was tested in a well-established preclinical heart failure model in which it induced a clear reversal to normal of the functional impairments in heart failure, such as Cardiac Output and Ejection Fraction. Moreover, histological reversal demonstrated an unprecedented rejuvenation of myocardial tissue.

Continue ReadingSaillant Therapeutics Reports Proof of Concept of Its Treatment In Heart Failure Showing Functional Reversal and Myocardial Rejuvenation